Folic Acid

• Methotrexate treatment in hand osteoarthritis refractory to usual treatments Pending
  2022-502362-24-00 Phase II 1 country Centre Hospitalier Universitaire De Nice
• SERORL Effect of aspirin and folic acid for sudden sensorineural hearing loss Pending
  2024-513710-35-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• REPO-HYPER II Recruiting
  2024-520231-33-00 Phase II 1 country Karolinska University Hospital
• ZANGEA – Phase II Study of Zanidatamab in Combination with Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesopha… Recruiting
  2025-522718-22-00 Phase II 1 country Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
• A randomized trial comparing efficacy and safety of etanercept and methotrexate in giant cell arteritis (EFFECTA) Recruiting
  2023-506623-29-01 Phase II 1 country Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy
• FASTERCC Recruiting
  2024-515413-18-00 Phase II 1 country Region Midtjylland
• Efficacy and Safety of Methotrexate versus Placebo in Adults with Atopic Dermatitis Ended
  2023-504443-13-00 Phase III 4 countries Medac Gesellschaft fuer klinische Spezialprapaerate mbH
• MEthotrexate versus TOcilizumab for treatment of GIant cell Arteritis: a multicenter, randomized, controlled trial Ended
  2024-512269-14-00 Phase III 1 country Centre Hospitalier Universitaire De Dijon
• A Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Subcutaneous CT-P13 in … Ended
  2024-510945-32-00 Phase III 1 country Celltrion Inc.

Showing 1–9 of 9 trials